Menu Back toStatistical Considerations in Safety Eveluation During the Life Cycle of a Drug Product

NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone


Statistical Considerations in Safety Eveluation During the Life Cycle of a Drug Product

Speaker(s)

Jessica  Kim

Jessica Kim

  • FDA, United States

Contact us

Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574